OTCPK:CLVSF (Sweden)  
CellaVision AB logo

CellaVision AB

$ 20.52 0 (0%) 11:08 PM EST
P/E:
47.72
P/B:
9.90
Market Cap:
$ 576.33M
Enterprise V:
$ 569.47M
Volume:
-
Avg Vol (2M):
100.00
Also Trade In:
Volume:
-
Market Cap $:
576.33M
PE Ratio:
47.72
Avg Vol (2-Month):
100.00
Enterprise Value $:
569.47M
PB Ratio:
9.90

Business Description

Description
CellaVision AB is engaged in the business of supplying digital solutions for blood and body fluid analysis. Its solutions are based on digital image analysis technology, artificial intelligence, and information technology. The firm's product portfolio consists of CellaVision peripheral blood application, CellaVision advanced RBC application, and CellaVision remote review software. Its customers include mainly large hospital laboratories and commercial laboratories in North America, Europe and China, and Japan. The company derives the majority of its revenue from the sale of analyzers.
Name Current Vs Industry Vs History
Cash-To-Debt 0.73
Equity-to-Asset 0.7
Debt-to-Equity 0.26
Debt-to-EBITDA 0.95
Interest Coverage 17.54
Piotroski F-Score 8/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 15.88
Distress
Grey
Safe
Beneish M-Score -2.54
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
6-1 Month Momentum % -23.21
12-1 Month Momentum % -35.37

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.93
Quick Ratio 1.9
Cash Ratio 0.93
Days Inventory 214.3
Days Sales Outstanding 50.33
Days Payable 62.95